儿童神经母细胞瘤的免疫治疗进展:通过生物标志物指导的联合方案克服耐药
Immunotherapeutic advances in pediatric neuroblastoma: Overcoming resistance through biomarker-guided combinations.
30.6分
★☆☆☆☆
站内排序·非疗效
ALL SOURCES
Immunotherapeutic advances in pediatric neuroblastoma: Overcoming resistance through biomarker-guided combinations.
Therapeutic Innovation in Pediatric Neuroblastoma: Age and Stage-Specific Strategies from Prenatal to Early Childhood-A Review Article.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。